Topos Bio
San Francisco
About Topos Bio
Topos Bio is an AI-powered biotechnology company developing therapies for intrinsically disordered proteins (IDPs). The company’s platform integrates physics with generative AI to target proteins involved in neurodegeneration, oncology, and metabolic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $10.5M
- Funding stage: Seed
- Last round: Seed (Jan 2026)
- Website: toposbio.ai
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/topos-bio-103957 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.